STOCKWATCH
·
Pharmaceuticals
Deals9 Dec 2024, 10:50 pm

Bajaj Healthcare Ltd Enters Into CDMO Contract With UK/EU Companies For 15 New APIs

AI Summary

Bajaj Healthcare Ltd has entered into a definitive CDMO contract with UK/EU based companies for 15 new APIs. This is in addition to 15 molecules for which the company entered the contract with UK/EU based clients on 27th February 2024. The new CDMO pipeline has a mix of off-Patent Generic APIs and APIs which are still under patent. The company is likely to enter into few CDMO deals with clients in Australia, New Zealand and South Africa, after the approval of the site by the TGA.

Key Highlights

  • Bajaj Healthcare Ltd has entered into a CDMO contract with UK/EU based companies for 15 new APIs
  • The new CDMO pipeline has a mix of off-Patent Generic APIs and APIs which are still under patent
  • The company is likely to enter into few CDMO deals with clients in Australia, New Zealand and South Africa after TGA approval
  • The contract is worth an undisclosed amount
  • The deal is expected to strengthen Bajaj Healthcare's position in the global CDMO market
BAJAJHCARE
Pharmaceuticals
Bajaj Healthcare Ltd

Price Impact